Minostad (Minocycline Hydrochloride Dihydrate)

Minocycline Hydrochloride Dihydrate, the active ingredient in Minostad, is a tetracycline antibiotic presented as an oral tablet for systemic antibacterial use. It treats a range of susceptible bacterial infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Minostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑compliant distribution across multiple markets while adhering to EU manufacturing standards.

Minocycline is a broad‑spectrum tetracycline antibiotic used to treat bacterial infections affecting various organ systems.

- Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin. - Community‑acquired pneumonia: effective against susceptible Streptococcus pneumoniae and atypical pathogens. - Skin and soft‑tissue infections: treats cellulitis, abscesses and infected wounds caused by susceptible organisms. - Lyme disease (early disseminated): eradicates Borrelia burgdorferi in appropriate clinical settings. - Urinary tract infections: clears susceptible Gram‑negative uropathogens.

Common side effects are generally mild and reversible.

Common Side Effects: - Nausea: transient stomach upset. - Vomiting: occasional emesis. - Diarrhoea: loose stools. - Photosensitivity: increased skin reaction to sunlight. - Dizziness: mild vertigo. - Headache: tension‑type pain.

Serious or Rare Side Effects: - Drug‑induced hepatitis: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering. - Anaphylaxis: rapid onset allergic reaction. - Intracranial hypertension: headache with visual changes. - Autoimmune hemolytic anemia: destruction of red blood cells. - Renal toxicity: impaired kidney function.

Before prescribing Minostad, clinicians should consider several safety factors.

- Assess renal and hepatic function: dose may need adjustment in impairment. - Monitor for photosensitivity: advise patients to avoid excessive sunlight. - Evaluate for hypersensitivity: discontinue if rash or angioedema occurs. - Use caution in pregnancy: only if benefits outweigh risks. - Avoid in children under 8 years: risk of permanent tooth discoloration. - Store at room temperature: keep in original container, protect from moisture and light.

Minostad can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: decrease absorption of minocycline. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Oral contraceptives: may reduce contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Penicillins: antagonistic effect may reduce antibacterial activity. - Methotrexate: increased risk of toxicity, especially at high doses.